These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30854168)

  • 1. Enhancing Natural Reward Responsiveness Among Opioid Users Predicts Chronic Pain Relief: EEG Analyses From a Trial of Mindfulness-Oriented Recovery Enhancement.
    Garland EL; Howard MO
    J Soc Social Work Res; 2018; 9(2):285-303. PubMed ID: 30854168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiological evidence for remediation of reward processing deficits in chronic pain and opioid misuse following treatment with Mindfulness-Oriented Recovery Enhancement: exploratory ERP findings from a pilot RCT.
    Garland EL; Froeliger B; Howard MO
    J Behav Med; 2015 Apr; 38(2):327-36. PubMed ID: 25385024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mindfulness-Oriented Recovery Enhancement remediates anhedonia in chronic opioid use by enhancing neurophysiological responses during savoring of natural rewards.
    Garland EL; Fix ST; Hudak JP; Bernat EM; Nakamura Y; Hanley AW; Donaldson GW; Marchand WR; Froeliger B
    Psychol Med; 2023 Apr; 53(5):2085-2094. PubMed ID: 37310337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Mindfulness-Oriented Recovery Enhancement on reward responsiveness and opioid cue-reactivity.
    Garland EL; Froeliger B; Howard MO
    Psychopharmacology (Berl); 2014 Aug; 231(16):3229-38. PubMed ID: 24595503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding and restoring dopaminergic function in fibromyalgia patients using a mindfulness-based psychological intervention: a [18F]-DOPA PET study. Study protocol for the FIBRODOPA study-a randomized controlled trial.
    Ledermann K; von Känel R; Berna C; Sprott H; Burckhardt M; Jenewein J; Garland EL; Martin-Sölch C
    Trials; 2021 Dec; 22(1):864. PubMed ID: 35078536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mindfulness-Oriented Recovery Enhancement remediates hedonic dysregulation in opioid users: Neural and affective evidence of target engagement.
    Garland EL; Atchley RM; Hanley AW; Zubieta JK; Froeliger B
    Sci Adv; 2019 Oct; 5(10):eaax1569. PubMed ID: 31663023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Mindfulness-Oriented Recovery Enhancement Versus Social Support on Negative Affective Interference During Inhibitory Control Among Opioid-Treated Chronic Pain Patients: A Pilot Mechanistic Study.
    Garland EL; Bryan MA; Priddy SE; Riquino MR; Froeliger B; Howard MO
    Ann Behav Med; 2019 Aug; 53(10):865-876. PubMed ID: 30668631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mindfulness-oriented recovery enhancement reduces opioid misuse risk via analgesic and positive psychological mechanisms: A randomized controlled trial.
    Garland EL; Hanley AW; Riquino MR; Reese SE; Baker AK; Salas K; Yack BP; Bedford CE; Bryan MA; Atchley R; Nakamura Y; Froeliger B; Howard MO
    J Consult Clin Psychol; 2019 Oct; 87(10):927-940. PubMed ID: 31556669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mindfulness-Oriented Recovery Enhancement vs Supportive Group Therapy for Co-occurring Opioid Misuse and Chronic Pain in Primary Care: A Randomized Clinical Trial.
    Garland EL; Hanley AW; Nakamura Y; Barrett JW; Baker AK; Reese SE; Riquino MR; Froeliger B; Donaldson GW
    JAMA Intern Med; 2022 Apr; 182(4):407-417. PubMed ID: 35226053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dispositional mindfulness and prescription opioid misuse among chronic pain patients: Craving and attention to positive information as mediating mechanisms.
    Priddy SE; Hanley AW; Riquino MR; Platt KA; Baker AK; Garland EL
    Drug Alcohol Depend; 2018 Jul; 188():86-93. PubMed ID: 29754031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain, hedonic regulation, and opioid misuse: Modulation of momentary experience by Mindfulness-Oriented Recovery Enhancement in opioid-treated chronic pain patients.
    Garland EL; Bryan CJ; Finan PH; Thomas EA; Priddy SE; Riquino MR; Howard MO
    Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S65-S72. PubMed ID: 28363322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial.
    Garland EL; Manusov EG; Froeliger B; Kelly A; Williams JM; Howard MO
    J Consult Clin Psychol; 2014 Jun; 82(3):448-459. PubMed ID: 24491075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial.
    Garland EL; Hanley AW; Kline A; Cooperman NA
    Drug Alcohol Depend; 2019 Oct; 203():61-65. PubMed ID: 31404850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mindfulness-oriented recovery enhancement improves negative emotion regulation among opioid-treated chronic pain patients by increasing interoceptive awareness.
    Roberts RL; Ledermann K; Garland EL
    J Psychosom Res; 2021 Nov; 152():110677. PubMed ID: 34801814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mindfulness-oriented recovery enhancement reduces pain attentional bias in chronic pain patients.
    Garland EL; Howard MO
    Psychother Psychosom; 2013; 82(5):311-8. PubMed ID: 23942276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoom-Based Mindfulness-Oriented Recovery Enhancement Plus Just-in-Time Mindfulness Practice Triggered by Wearable Sensors for Opioid Craving and Chronic Pain.
    Garland EL; Gullapalli BT; Prince KC; Hanley AW; Sanyer M; Tuomenoksa M; Rahman T
    Mindfulness (N Y); 2023 May; ():1-17. PubMed ID: 37362184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restructuring Hedonic Dysregulation in Chronic Pain and Prescription Opioid Misuse: Effects of Mindfulness-Oriented Recovery Enhancement on Responsiveness to Drug Cues and Natural Rewards.
    Garland EL; Howard MO; Zubieta JK; Froeliger B
    Psychother Psychosom; 2017; 86(2):111-112. PubMed ID: 28183077
    [No Abstract]   [Full Text] [Related]  

  • 18. Mindfulness-Oriented Recovery Enhancement Restructures Reward Processing and Promotes Interoceptive Awareness in Overweight Cancer Survivors: Mechanistic Results From a Stage 1 Randomized Controlled Trial.
    Thomas EA; Mijangos JL; Hansen PA; White S; Walker D; Reimers C; Beck AC; Garland EL
    Integr Cancer Ther; 2019; 18():1534735419855138. PubMed ID: 31165653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for the reduction of prescribed opioid use in chronic non-cancer pain.
    Eccleston C; Fisher E; Thomas KH; Hearn L; Derry S; Stannard C; Knaggs R; Moore RA
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD010323. PubMed ID: 29130474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.